X0306 4 2017-12-29 0001358762 REATA PHARMACEUTICALS INC RETA 0001372218 CPMG Inc 2000 MCKINNEY AVE, STE 2125 DALLAS TX 75201 true true Class A common stock 2017-12-29 4 P 0 17000 28.4715 A 44200 I By Barred Owl Partners, LP Class A common stock 34897 I By Managed Account for Trustees of the University of Pennsylvania Class A common stock 442560 I By Gallopavo, LP Class A common stock 748253 I By Roadrunner Fund, LP Class A common stock 103185 I By Blackwell Partners LLC Class A common stock 431155 I By Yellow Warbler, LP Class A common stock 110640 I By Killdeer Fund, LP Class A common stock 109415 I By Mallard Fund, LP Class A common stock 280500 I By Willet Fund, LP Class A common stock 37909 I By Crested Crane, LP Class A common stock 63481 I By Flamingo Fund, LP Class A common stock 334740 I By Sandpiper Fund, LP Class A common stock 160265 I By Kestrel Fund, LP Class A common stock 11076 I By CD Fund, LP Class A common stock 134 I By Redbird Life Sciences Partners, LP Class A common stock 113 D This price reflects the weighted average purchase price for open-market purchases on December 29, 2017, within a $1.00 range. The actual prices for these transactions range from $28.40 to $28.50 inclusive. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. The Reporting Person is the investment manager of each of: Barred Owl Partners, LP; Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Mr. McGaughy, Jr., a co-director and co-shareholder of the Reporting Person, serves on the Issuer's Board of Directors (the "Board") as a representative of the Reporting Person. By virtue of his representation on the Board, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the Reporting Person is deemed to be a director by deputization. /s/ John Bateman, Chief Operating Officer of CPMG, Inc. 2017-12-29